Pharmaceutical manufacturing

Speaker of the House Nancy Pelosi, D-Calif., arrives for a gathering of the House Democratic Caucus at the Capitol in Washington, Tuesday, Sept. 10, 2019. A leaked draft proposal from Pelosi says Medicare should overhaul how it pays for prescription drugs, by negotiating prices for the costliest medications, curbing year-to-year price hikes, and limiting what seniors pay out of their own pockets. (AP Photo/J. Scott Applewhite)
1010 WINS Newsroom
September 10, 2019 - 5:19 pm
WASHINGTON (AP) — A draft plan from House Speaker Nancy Pelosi leaked Tuesday would overhaul how Medicare pays for prescription drugs, by negotiating prices for costly medications, curbing annual price hikes, and limiting what seniors pay out of their own pockets. With President Donald Trump highly...
Read More
1010 WINS Newsroom
September 04, 2019 - 6:53 pm
A drugmaker has agreed to pay $15.4 million to settle claims that a company it bought had it lavished doctors with dinners and entertainment to encourage them to keep prescribing a drug as its price ballooned. Under an agreement announced Wednesday by the U.S. Department of Justice, Britain-based...
Read More
FILE - In this Thursday, March 14, 2008 file photo, a woman rides a bicycle past Changzhou SPL in Changzhou, China. The FDA did not open its first permanent offices in China and India until 2008 and 2009, respectively. That followed dozens of deaths and hundreds of allergic reactions in the U.S. linked to the contaminated blood thinner heparin made at this Chinese facility. (AP Photo/Eugene Hoshiko)
1010 WINS Newsroom
August 28, 2019 - 10:44 pm
WASHINGTON (AP) — U.S. health officials on Wednesday tried to reassure patients that they face very low risks from ongoing contamination problems with widely prescribed blood pressure drugs. Drugmakers have issued more than 50 recalls since last July linked to low levels of a probable cancer-...
Read More
Democratic presidential candidate former Vice President Joe Biden speaks during a campaign event at Keene State College in Keene, N.H., Saturday, Aug. 24, 2019. (AP Photo/Michael Dwyer)
1010 WINS Newsroom
August 27, 2019 - 4:57 pm
WASHINGTON (AP) — Wrapping himself in the legacy of "Obamacare," Joe Biden is offering restless Democrats a health care proposal that goes far beyond it, calling for a government plan almost anybody can join but stopping short of a total system remake. Recent polls show softening support for the...
Read More
Britain's Prime Minister Boris Johnson talks to hospital patient Scarlett Gibbons, 5, during a visit to the Royal Cornwall Hospital in Truro, south-west England, Monday Aug. 19, 2019. Johnson is under increasing pressure Monday to recall Parliament after leaked government documents warned of widespread problems if the U.K. leaves the European Union without a Brexit withdrawal agreement. (Peter Nicholls/Pool via AP)
August 19, 2019 - 7:19 pm
LONDON (AP) — Britain's government plans to call a summit of social media companies to discuss what more they can do to fight online misinformation about vaccines following a spike in measles cases. Although plans for such a gathering were still being worked out, Prime Minister Boris Johnson...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 4:41 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the...
Read More
This photo provided by Novartis shows their gene therapy medicine Zolgensma. U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after they approved the Swiss drugmaker’s $2.125 million gene therapy. On Tuesday, Aug. 6, 2019, the Food and Drug Administration said the questionable data involves testing of the therapy, Zologensma, on animals, not on patients. (Novartis via AP)
August 06, 2019 - 6:51 pm
TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after the Swiss drugmaker's $2.1 million gene therapy was approved. The Food and Drug Administration said Tuesday the manipulated data involved testing in animals, not patients, and it's...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 4:46 pm
WASHINGTON (AP) — The Trump administration said Wednesday it will create a way for Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of refusals by health authorities amid a public outcry over high prices for life-sustaining...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 2:31 pm
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from slightly reduced spending on research and...
Read More
FILE - In this June 18, 2019, file photo, U.S. Trade Representative Robert Lighthizer testifies before the Senate Finance Committee on Capitol Hill in Washington. Congressional Democrats appear to be moving from “no way’’ to “maybe’’ on President Donald Trump’s rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with Lighthizer, most recently on Friday, July 26, and both sides say they are making progress toward a deal that would clear the way for Congress to approve Trump’s U.S.-Mexico-Canada Agreement, or USMCA. (AP Photo/Susan Walsh, File)
July 30, 2019 - 12:30 am
WASHINGTON (AP) — Congressional Democrats appear to be moving from "no way" to "maybe" on President Donald Trump's rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with U.S. Trade Representative Robert Lighthizer, most recently on Friday, and both sides say they...
Read More

Pages